A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis

Srilakshmi M Sharma; Dun Jack Fu; Kanmin Xue

doi:10.1007/s40123-017-0115-5

A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis

Ophthalmol Ther. 2018 Jun;7(1):1-17. doi: 10.1007/s40123-017-0115-5. Epub 2017 Nov 30.

Authors

Srilakshmi M Sharma^{1

2}, Dun Jack Fu³, Kanmin Xue^{3

4}

Affiliations

¹ Oxford University Hospitals NHS Foundation Trust, Oxford Eye Hospital, Oxford, UK. Srilakshmi.sharma@ouh.nhs.uk.
² Nuffield Laboratory of Ophthalmology, West Wing, John Radcliffe Hospital, University of Oxford, Oxford, UK. Srilakshmi.sharma@ouh.nhs.uk.
³ Oxford University Hospitals NHS Foundation Trust, Oxford Eye Hospital, Oxford, UK.
⁴ Nuffield Laboratory of Ophthalmology, West Wing, John Radcliffe Hospital, University of Oxford, Oxford, UK.

Abstract

Systemic immunomodulatory therapies are the principal means of managing non-infectious uveitis. This review aims to explore the current landscape of systemic uveitis treatments, including biologic therapies and the advent of biosimilar therapies.

Keywords: Biologics; Biosimilars; Interferon; Interleukins; Non-infectious uveitis; TNFα inhibitors.

Publication types

Review